# Clinical Deployment Plan - OncoSML mRNA Vaccine System

**Document ID:** SML-CDP-001  
**Version:** 1.0  
**Effective Date:** 2026-04-06  
**Classification:** GMP-Controlled Document  

---

## Executive Summary

This document outlines the comprehensive plan to transform the OncoSML research system into a clinical-grade software platform suitable for regulatory submission and clinical trial use.

### Current State
- **Software Status:** Research-grade, functional
- **Modules Operational:** 6/6 (immunogenicity, HLA binding, mRNA optimization, PK modeling, clinical validator, report generator)
- **Validation Status:** Research validation complete
- **Compliance Status:** Not compliant with 21 CFR Part 11, GMP, HIPAA/GDPR

### Target State
- **Software Status:** Clinical-grade, validated
- **Compliance:** 21 CFR Part 11, GMP, HIPAA/GDPR compliant
- **Validation:** Full IQ/OQ/PQ completed
- **Security:** Enterprise-grade with audit trails

---

## Phase 1: Software Validation Framework (Weeks 1-4)

### 1.1 Validation Master Plan

**Document:** `docs/VALIDATION_MASTER_PLAN.md`

Create comprehensive validation documentation:
- Validation Policy and Objectives
- System Description and Architecture
- Risk Assessment (GAMP 5 Category 4)
- Validation Schedule and Responsibilities

### 1.2 Requirements Specification

**Document:** `docs/USER_REQUIREMENTS_SPECIFICATION.md`

Define functional and technical requirements:
- Functional Requirements (FR-001 to FR-XXX)
- Technical Requirements (TR-001 to TR-XXX)
- Regulatory Requirements (RR-001 to RR-XXX)
- Performance Requirements (PR-001 to PR-XXX)

### 1.3 Design Specification

**Document:** `docs/DESIGN_SPECIFICATION.md`

Document system design:
- System Architecture Diagram
- Data Flow Diagrams
- Interface Specifications
- Database Schema
- Security Architecture

### 1.4 Risk Assessment

**Document:** `docs/RISK_ASSESSMENT.md`

Perform GAMP 5 risk assessment:
- Software Category Assessment (Category 4 - Configured Product)
- Functional Risk Assessment
- Data Integrity Risk Assessment
- Patient Safety Impact Assessment
- Mitigation Strategies

---

## Phase 2: GMP Compliance Implementation (Weeks 5-8)

### 2.1 21 CFR Part 11 Compliance

**Implementation:** `sml/compliance/`

#### Electronic Signatures
```python
# sml/compliance/electronic_signatures.py
- Digital signature implementation
- Signature manifestation
- Signature/record linking
- Non-repudiation controls
```

#### Audit Trails
```python
# sml/compliance/audit_trail.py
- Comprehensive audit logging
- User action tracking
- Data change tracking
- Secure audit trail storage
- Audit trail review procedures
```

### 2.2 Quality Management System

**Documents:**
- `docs/SOP-001_Software_Development.md`
- `docs/SOP-002_Change_Control.md`
- `docs/SOP-003_Document_Control.md`
- `docs/SOP-004_Training.md`
- `docs/SOP-005_Incident_Management.md`
- `docs/SOP-006_Backup_Restore.md`

### 2.3 Good Documentation Practices (GDP)

**Implementation:**
- ALCOA+ principles for data integrity
- Contemporaneous recording
- Original records
- Accurate data
- Legible documentation
- Attributable actions

---

## Phase 3: Security & Privacy Implementation (Weeks 9-12)

### 3.1 Access Control System

**Implementation:** `sml/security/access_control.py`

- Role-based access control (RBAC)
- Multi-factor authentication
- Session management
- Password policies
- Account lockout policies

### 3.2 Data Encryption

**Implementation:** `sml/security/encryption.py`

- AES-256 encryption at rest
- TLS 1.3 encryption in transit
- Key management system
- Certificate management

### 3.3 HIPAA/GDPR Compliance

**Implementation:** `sml/compliance/privacy.py`

- Patient data de-identification
- Data minimization
- Consent management
- Right to erasure
- Data portability
- Breach notification procedures

### 3.4 Security Monitoring

**Implementation:** `sml/security/monitoring.py`

- Intrusion detection
- Security event logging
- Anomaly detection
- Security incident response

---

## Phase 4: Infrastructure & Deployment (Weeks 13-16)

### 4.1 Containerization

**Files:**
- `Dockerfile.clinical` - Clinical-grade Docker image
- `docker-compose.clinical.yml` - Production deployment
- `kubernetes/` - K8s deployment manifests

### 4.2 Database Implementation

**Implementation:** PostgreSQL with:
- Encrypted storage
- Audit logging
- Backup/restore procedures
- High availability configuration

### 4.3 Backup & Disaster Recovery

**Documents:**
- `docs/BACKUP_PROCEDURE.md`
- `docs/DISASTER_RECOVERY_PLAN.md`
- `docs/BUSINESS_CONTINUITY_PLAN.md`

### 4.4 Environment Separation

- Development Environment (DEV)
- Testing Environment (TEST)
- Validation Environment (VAL)
- Production Environment (PROD)

---

## Phase 5: Testing & Validation (Weeks 17-20)

### 5.1 Installation Qualification (IQ)

**Document:** `validation/IQ_Installation_Qualification.md`

- Hardware verification
- Software installation verification
- Network configuration verification
- Security configuration verification

### 5.2 Operational Qualification (OQ)

**Document:** `validation/OQ_Operational_Qualification.md`

- Functional testing
- Interface testing
- Security testing
- Performance testing
- Error handling testing

### 5.3 Performance Qualification (PQ)

**Document:** `validation/PQ_Performance_Qualification.md`

- End-to-end workflow testing
- User acceptance testing
- Load testing
- Stress testing
- Recovery testing

### 5.4 Test Scripts

**Directory:** `validation/test_scripts/`

- `TS-001_User_Authentication.py`
- `TS-002_Neoantigen_Prediction.py`
- `TS-003_Report_Generation.py`
- `TS-004_Audit_Trail.py`
- `TS-005_Data_Integrity.py`
- `TS-006_Backup_Restore.py`

---

## Phase 6: Documentation Package (Weeks 21-24)

### 6.1 Regulatory Submission Package

**Documents:**
- `docs/REGULATORY_SUBMISSION_INDEX.md`
- Software Description Document
- Validation Summary Report
- Risk Assessment Report
- User Manual
- Technical Reference Manual

### 6.2 Clinical Trial Documentation

**Documents:**
- `docs/INVESTIGATOR_BROCHURE_SOFTWARE.md`
- `docs/CLINICAL_PROTOCOL_SOFTWARE_SECTION.md`
- `docs/TECHNICAL_SPECIFICATIONS.md`

### 6.3 Training Materials

**Documents:**
- `docs/TRAINING_MANUAL.md`
- `docs/QUICK_REFERENCE_GUIDE.md`
- `docs/VIDEO_TUTORIALS/`
- Training assessment forms

---

## Implementation Timeline

| Phase | Duration | Deliverables |
|-------|----------|--------------|
| Phase 1: Validation Framework | Weeks 1-4 | VMP, URS, DS, RA |
| Phase 2: GMP Compliance | Weeks 5-8 | 21 CFR Part 11, QMS, SOPs |
| Phase 3: Security & Privacy | Weeks 9-12 | Access control, encryption, HIPAA/GDPR |
| Phase 4: Infrastructure | Weeks 13-16 | Containers, database, DR |
| Phase 5: Testing & Validation | Weeks 17-20 | IQ/OQ/PQ, test scripts |
| Phase 6: Documentation | Weeks 21-24 | Regulatory package, training |

**Total Duration:** 24 weeks (6 months)

---

## Resource Requirements

### Personnel
- **Validation Specialist:** 1 FTE
- **Software Engineer:** 2 FTE
- **QA/RA Specialist:** 1 FTE
- **Security Engineer:** 1 FTE
- **Clinical Affairs Specialist:** 0.5 FTE

### Infrastructure
- **Development Servers:** 2
- **Validation Environment:** 1
- **Production Environment:** 1 (HA cluster)
- **Backup Storage:** Encrypted, off-site

### Budget Estimate
- **Personnel:** $1.2M
- **Infrastructure:** $200K
- **Validation/Testing:** $150K
- **Regulatory Consulting:** $100K
- **Contingency (15%):** $247.5K
- **Total:** ~$1.9M

---

## Success Criteria

### Go/No-Go Decision Points

**Phase 1 Gate (Week 4):**
- ✅ Validation Master Plan approved
- ✅ Requirements specification complete
- ✅ Risk assessment complete

**Phase 2 Gate (Week 8):**
- ✅ 21 CFR Part 11 compliance implemented
- ✅ QMS documentation complete
- ✅ SOPs approved

**Phase 3 Gate (Week 12):**
- ✅ Security controls implemented
- ✅ HIPAA/GDPR compliance verified
- ✅ Penetration testing passed

**Phase 4 Gate (Week 16):**
- ✅ Production infrastructure deployed
- ✅ Backup/DR tested
- ✅ Environment separation validated

**Phase 5 Gate (Week 20):**
- ✅ IQ/OQ/PQ completed
- ✅ All test scripts passed
- ✅ User acceptance testing complete

**Phase 6 Gate (Week 24):**
- ✅ Regulatory submission package complete
- ✅ Training materials complete
- ✅ System ready for clinical use

---

## Post-Deployment Activities

### Ongoing Compliance
- Annual system reviews
- Periodic risk assessments
- Continuous monitoring
- Change control management

### Maintenance
- Regular security patches
- Performance monitoring
- User support
- System upgrades

### Regulatory
- Annual reports
- Adverse event reporting
- Inspection readiness
- Continuous compliance

---

## Approval

**Prepared By:** ___________________ Date: _________

**Reviewed By (QA):** ___________________ Date: _________

**Approved By (Management):** ___________________ Date: _________

---

*This document is controlled under the Quality Management System. Unauthorized copying or distribution is prohibited.*